Brodalumab efficacy in bio-naïve psoriasis patients: real-life experience of 202 subjects up to 48 weeks

Luca MastorinoDermatology Clinic, Section of Dermatology, Department of Medical Sciences, University of Turin, Turin, ItalyCorrespondence[email protected]

https://orcid.org/0000-0001-7386-3219

C. CaritiDermatology Clinic, Section of Dermatology, Department of Medical Sciences, University of Turin, Turin, Italy

S. SuscaDermatology Clinic, Section of Dermatology, Department of Medical Sciences, University of Turin, Turin, Italy

S. BoskovicDermatology Clinic, Section of Dermatology, Department of Medical Sciences, University of Turin, Turin, Italy

C. AquinoDermatology Clinic, Section of Dermatology, Department of Medical Sciences, University of Turin, Turin, Italy

M. OrtoncelliDermatology Clinic, Section of Dermatology, Department of Medical Sciences, University of Turin, Turin, Italy

E. StroppianaDermatology Clinic, Section of Dermatology, Department of Medical Sciences, University of Turin, Turin, Italy

A. VerroneDermatology Clinic, Section of Dermatology, Department of Medical Sciences, University of Turin, Turin, Italy

P. DapavoDermatology Clinic, Section of Dermatology, Department of Medical Sciences, University of Turin, Turin, Italy

P. QuaglinoDermatology Clinic, Section of Dermatology, Department of Medical Sciences, University of Turin, Turin, Italy

Simone RiberoDermatology Clinic, Section of Dermatology, Department of Medical Sciences, University of Turin, Turin, Italy

https://orcid.org/0000-0002-0098-1406

show all

References

Gisondi P, Girolomoni G. Brodalumab in the treatment of chronic plaque psoriasis. Expert Opin Biol Ther. 2020;20(10):1175–1186.
PubMed Web of Science ®Google Scholar
Iznardo H, Puig L. The safety of brodalumab for the treatment of psoriasis. Expert Opin Drug Saf. 2020;19(4):365–372.
PubMed Web of Science ®Google Scholar
Papp KA, Reich K, Paul C, et al. A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis. Br J Dermatol. 2016;175(2):273–286.
PubMed Web of Science ®Google Scholar
Dapavo P, Siliquini N, Mastorino L, et al. Efficacy, safety, and drug survival of IL-23, IL-17, and TNF-alpha inhibitors for psoriasis treatment: a retrospective study. J Dermatolog Treat. 2022;33(4):2352–2357.
PubMed Web of Science ®Google Scholar
Galluzzo M, Caldarola G, De Simone C, et al. Use of brodalumab for the treatment of chronic plaque psoriasis: a one-year real-life study in the Lazio region, Italy. Expert Opin Biol Ther. 2021;21(9):1299–1310.
PubMed Web of Science ®Google Scholar
Fargnoli MC, Esposito M, Dapavo P, et al. Brodalumab for the treatment of moderate-to-severe plaque-type psoriasis: a real-life, retrospective 24-week experience. J Eur Acad Dermatol Venereol. 2021;35(3):693–700.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Brodalumab efficacy in bio-naïve psoriasis patients: real-life experience of 202 subjects up to 48 weeks

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Brodalumab efficacy in bio-naïve psoriasis patients: real-life experience of 202 subjects up to 48 weeks

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date